GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis
Tefferi, Ayalew, Guglielmelli, Paola, Nicolosi, Maura, Mannelli, Francesco, Mudireddy, Mythri, Bartalucci, Niccolo, Finke, Christy M, Lasho, Terra L, Hanson, Curtis A, Ketterling, Rhett P, Begna, Kebede H, Naseema Gangat, Pardanani, Animesh, Vannucchi, Alessandro M
Published in Leukemia (01.07.2018)
Published in Leukemia (01.07.2018)
Get full text
Journal Article
Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients
Tefferi, Ayalew, Nicolosi, Maura, Mudireddy, Mythri, Lasho, Terra L, Gangat, Naseema, Begna, Kebede H, Hanson, Curtis A, Ketterling, Rhett P, Pardanani, Animesh
Published in Leukemia (01.05.2018)
Published in Leukemia (01.05.2018)
Get full text
Journal Article
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
Tefferi, Ayalew, Lasho, Terra L, Begna, Kebede H, Patnaik, Mrinal M, Zblewski, Darci L, Finke, Christy M, Laborde, Rebecca R, Wassie, Emnet, Schimek, Lauren, Hanson, Curtis A, Gangat, Naseema, Wang, Xiaolin, Pardanani, Animesh
Published in The New England journal of medicine (03.09.2015)
Published in The New England journal of medicine (03.09.2015)
Get full text
Journal Article
Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors
Abu Rmilah, Anan A., Lin, Grace, Begna, Kebede H., Friedman, Paul A., Herrmann, Joerg
Published in International journal of cancer (01.12.2020)
Published in International journal of cancer (01.12.2020)
Get full text
Journal Article
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts
Tefferi, Ayalew, Mudireddy, Mythri, Mannelli, Francesco, Begna, Kebede H, Patnaik, Mrinal M, Hanson, Curtis A, Ketterling, Rhett P, Gangat, Naseema, Yogarajah, Meera, De Stefano, Valerio, Passamonti, Francesco, Rosti, Vittorio, Finazzi, Maria Chiara, Rambaldi, Alessandro, Bosi, Alberto, Guglielmelli, Paola, Pardanani, Animesh, Vannucchi, Alessandro M
Published in Leukemia (01.05.2018)
Published in Leukemia (01.05.2018)
Get full text
Journal Article
DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
GANGAT, Naseema, CARAMAZZA, Domenica, CERVANTES, Francisco, PASSAMONTI, Francesco, TEFFERI, Ayalew, VAIDYA, Rakhee, GEORGE, Geeta, BEGNA, Kebede, SCHWAGER, Susan, VAN DYKE, Daniel, HANSON, Curtis, WENTING WU, PARDANANI, Animesh
Published in Journal of clinical oncology (01.02.2011)
Published in Journal of clinical oncology (01.02.2011)
Get full text
Journal Article
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients
Morsia, Erika, McCullough, Kristen, Joshi, Maansi, Cook, Joselle, Alkhateeb, Hassan B., Al‐Kali, Aref, Begna, Kebede, Elliott, Michelle, Hogan, William, Litzow, Mark, Shah, Mithun, Pardanani, Animesh, Patnaik, Mrinal, Tefferi, Ayalew, Gangat, Naseema
Published in American journal of hematology (01.12.2020)
Published in American journal of hematology (01.12.2020)
Get full text
Journal Article
Tyrosine kinase inhibitors dosing for chronic phase chronic myeloid leukemia: The case for starting low with dasatinib (50 mg/day) and ponatinib (15 mg/day)
Tefferi, Ayalew, Begna, Kebede H., McCullough, Kristen B.
Published in American journal of hematology (01.11.2022)
Published in American journal of hematology (01.11.2022)
Get full text
Journal Article
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
Szuber, Natasha, Mudireddy, Mythri, Nicolosi, Maura, Penna, Domenico, Vallapureddy, Rangit R., Lasho, Terra L., Finke, Christy, Begna, Kebede H., Elliott, Michelle A., Hook, C. Christopher, Wolanskyj, Alexandra P., Patnaik, Mrinal M., Hanson, Curtis A., Ketterling, Rhett P., Sirhan, Shireen, Pardanani, Animesh, Gangat, Naseema, Busque, Lambert, Tefferi, Ayalew
Published in Mayo Clinic proceedings (01.04.2019)
Published in Mayo Clinic proceedings (01.04.2019)
Get full text
Journal Article
One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience
Tefferi, Ayalew, MD, Lasho, Terra L., MT, Jimma, Thitina, MD, Finke, Christy M., BS, Gangat, Naseema, MBBS, Vaidya, Rakhee, MBBS, Begna, Kebede H., MD, Al-Kali, Aref, MD, Ketterling, Rhett P., MD, Hanson, Curtis A., MD, Pardanani, Animesh, MBBS, PhD
Published in Mayo Clinic proceedings (2012)
Published in Mayo Clinic proceedings (2012)
Get full text
Journal Article
Clinical Heterogeneity of the VEXAS Syndrome: A Case Series
Koster, Matthew J, Kourelis, Taxiarchis, Reichard, Kaaren K, Kermani, Tanaz A, Beck, David B, Cardona, Daniela Ospina, Samec, Matthew J, Mangaonkar, Abhishek A, Begna, Kebede H, Hook, C Christopher, Oliveira, Jennifer L, Nasr, Samih H, Tiong, Benedict K, Patnaik, Mrinal M, Burke, Michelle M, Michet, Jr, Clement J, Warrington, Kenneth J
Published in Mayo Clinic proceedings (01.10.2021)
Published in Mayo Clinic proceedings (01.10.2021)
Get more information
Journal Article
Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding
Iyer, Vivek N., Apala, Dinesh R., Pannu, Bibek S., Kotecha, Aditya, Brinjikji, Waleed, Leise, Michael D., Kamath, Patrick S., Misra, Sanjay, Begna, Kebede H., Cartin-Ceba, Rodrigo, DuBrock, Hilary M., Krowka, Michael J., O'Brien, Erin K., Pruthi, Rajiv K., Schroeder, Darrell R., Swanson, Karen L.
Published in Mayo Clinic proceedings (01.02.2018)
Published in Mayo Clinic proceedings (01.02.2018)
Get full text
Journal Article
Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant
Begna, Kebede H, Abdallah, Nadine H, Janania-Martinez, Michelle, Mangaonkar, Abhishek A, Rangan, Aruna, Herrick, Jennifer L, Gangat, Naseema
Published in Haematologica (Roma) (01.02.2024)
Published in Haematologica (Roma) (01.02.2024)
Get full text
Journal Article
Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor
Gangat, Naseema, Begna, Kebede H, Al-Kali, Aref, Hogan, William, Litzow, Mark, Pardanani, Animesh, Tefferi, Ayalew
Published in Blood cancer journal (New York) (04.01.2023)
Published in Blood cancer journal (New York) (04.01.2023)
Get full text
Journal Article
Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy
Gangat, Naseema, Ilyas, Rimal, Johnson, Isla M, McCullough, Kristen, Al-Kali, Aref, Alkhateeb, Hassan B, Begna, Kebede H, Mangaonkar, Abhishek, Litzow, Mark R, Hogan, William, Shah, Mithun, Patnaik, Mrinal M, Pardanani, Animesh, Tefferi, Ayalew
Published in Haematologica (Roma) (01.11.2023)
Published in Haematologica (Roma) (01.11.2023)
Get full text
Journal Article
Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia
Gangat, Naseema, Johnson, Isla, McCullough, Kristen, Farrukh, Faiqa, Al-Kali, Aref, Alkhateeb, Hassan, Begna, Kebede, Mangaonkar, Abhishek, Litzow, Mark, Hogan, William, Shah, Mithun, Patnaik, Mrinal, Pardanani, Animesh, Tefferi, Ayalew
Published in Haematologica (Roma) (01.10.2022)
Published in Haematologica (Roma) (01.10.2022)
Get full text
Journal Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases
Gangat, Naseema, Guglielmelli, Paola, Szuber, Natasha, Begna, Kebede H., Patnaik, Mrinal M., Litzow, Mark R., Al‐Kali, Aref, Foran, James M., Palmer, Jeanne M., Alkhateeb, Hassan, Elliott, Michelle A., Hanson, Curtis A., Pardanani, Animesh, Mannelli, Francesco, Vannucchi, Alessandro M., Tefferi, Ayalew
Published in American journal of hematology (01.07.2021)
Published in American journal of hematology (01.07.2021)
Get full text
Journal Article
Sodium‐glucose co‐transporter‐2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases
Gangat, Naseema, Abdallah, Mostafa, Szuber, Natasha, Saliba, Antoine, Alkhateeb, Hassan, Al‐Kali, Aref, Begna, Kebede H., Pardanani, Animesh, Tefferi, Ayalew
Published in American journal of hematology (01.07.2023)
Published in American journal of hematology (01.07.2023)
Get full text
Journal Article
Prediction of early (4‐week) mortality in acute myeloid leukemia with intensive chemotherapy
Sasaki, Koji, Kadia, Tapan, Begna, Kebede, DiNardo, Courtney D., Borthakur, Gautam, Short, Nicholas J., Jain, Nitin, Daver, Naval, Jabbour, Elias, Garcia‐Manero, Guillermo, Bravo, Guillermo Montalban, Masarova, Lucia, Pierce, Sherry, Konopleva, Marina, Ravandi, Farhad, Tefferi, Ayalew, Kantarjian, Hagop
Published in American journal of hematology (01.01.2022)
Published in American journal of hematology (01.01.2022)
Get full text
Journal Article